Table 3.
Patient | Preg | Year | Prospectively Followed | Maintenance Plasma Therapy before Pregnancy | Plasma Therapy during Pregnancy | Start (Gestational Week) | Stop (Postpartum Week) | TMA Episode |
---|---|---|---|---|---|---|---|---|
A.1 | 1 | 2009 | yes | none | 3 ml/kg twice monthly | 15 | continued | no |
2 | 2012 | yes | none | 3 ml/kg twice monthly | 13 | continued | no | |
A.2 | 1 | 2010 | yes | none | 2.5 ml/kg twice monthly | 14 | continued | no |
2 | 2011 | yes | none | none | — | — | no | |
3 | 2014 | yes | none | none | — | — | no | |
C.1 | 1 | 2011a | no | none | none | — | — | yes |
2 | 2014 | yes | none | 10 ml/kg twice monthly | 21 | 14 | no | |
3 | 2015 | yes | none | 10 ml/kg twice monthly | 15 | 24 | no | |
C.6 | 1 | 2002a | no | none | none | — | — | nob |
2 | 2013 | yes | 25 ml/kg monthly | 25 ml/kg twice monthly | 14 | 19 | no | |
3 | 2015 | yes | 25 ml/kg monthly | 25 ml/kg monthly | — | 1c | yes |
Preg, pregnancy.
Pregnancy before follow-up at our department.
Presented with acute and chronic TMA in renal biopsy 12 mo after delivery.
Switch to eculizumab.